The relationship between arterial stiffness and nonalcoholic fatty liver disease

Digestive Diseases and Sciences

Volumn 57, Issue 1, 2012, Pages 196-203

  Lee, Yong Jae ^a   Shim, Jae Yong ^a   Moon, Byung Soo ^a   Shin, Youn Ho ^b   Jung, Dong Hyuk ^a   Lee, Jung Hyun ^c   Lee, Hye Ree ^a  

^a Yonsei University College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Arterial stiffness; Cardiovascular disease; Inflammation; Nonalcoholic fatty liver disease; Pulse wave velocity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOGRAPHY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; PULSE WAVE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANKLE BRACHIAL INDEX; CARDIOVASCULAR DISEASES; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84856708597     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1819-3     Document Type: Article

References (34)

1. P Angulo 2007 GI epidemiology: nonalcoholic fatty liver disease Aliment Pharmacol Ther 25 883 889 17402991 10.1111/j.1365-2036.2007.03246.x 1:STN:280:DC%2BD2s3gtVyrtA%3D%3D
2. CA Matteoni ZM Younossi T Gramlich N Boparai YC Liu AJ McCullough 1999 Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1413 1419 10348825 10.1016/S0016-5085(99)70506-8 1:STN:280:DyaK1M3nvVamtw%3D%3D (Pubitemid 29258890)
3. G Marchesini M Brizi G Bianchi, et al. 2001 Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 1844 1850 11473047 10.2337/diabetes.50.8.1844 1:CAS:528:DC%2BD3MXlslKmsr4%3D (Pubitemid 33641605)
4. G Targher CP Day E Bonora 2010 Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N Engl J Med 363 1341 1350 20879883 10.1056/NEJMra0912063 1:CAS:528:DC%2BC3cXht1Wqt7vO
5. M Ekstedt LE Franzén UL Mathiesen, et al. 2006 Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 865 873 17006923 10.1002/hep.21327 1:CAS:528:DC%2BD28XhtFyqsrzN (Pubitemid 46489550)
6. JJ Oliver DJ Webb 2003 Noninvasive assessment of arterial stiffness and risk of atherosclerotic events Arterioscler Thromb Vascular Biol 23 554 566 10.1161/01.ATV.0000060460.52916.D6 1:CAS:528:DC%2BD3sXisFKgtL8%3D (Pubitemid 36438066)
7. NM van Popele DE Grobbee ML Bots, et al. 2001 Association between arterial stiffness and atherosclerosis: the Rotterdam study Stroke 32 454 460 11157182 10.1161/01.STR.32.2.454 (Pubitemid 32155234)
8. A Yamashina H Tomiyama T Arai, et al. 2003 Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk Hypertens Res 26 615 622 14567500 10.1291/hypres.26.615 (Pubitemid 37080794)
9. P Boutouyrie AI Tropeano R Asmar, et al. 2002 Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study Hypertension 39 10 15 11799071 10.1161/hy0102.099031 1:CAS:528:DC%2BD38XpsF2gug%3D%3D (Pubitemid 34098081)
10. YJ Kim YJ Kim BM Cho S Lee 2010 Metabolic syndrome and arterial pulse wave velocity Acta Cardiol 65 315 321 20666270 10.2143/AC.65.3.2050348
11. H Tanaka M Munakata Y Kawano, et al. 2009 Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness J Hypertens 27 2022 2027 19550355 10.1097/HJH.0b013e32832e94e7 1:CAS:528:DC%2BD1MXhtFGlu7%2FO
12. SK Seo S Cho HY Kim, et al. 2009 Bone mineral density, arterial stiffness, and coronary atherosclerosis in healthy postmenopausal women Menopause 16 937 943 19387416 10.1097/gme.0b013e3181a15552
13. SH Saverymuttu AE Joseph JD Maxwell 1986 Ultrasound scanning in the detection of hepatic fibrosis and steatosis Br Med J 292 13 15 10.1136/bmj.292.6512.13 1:STN:280:DyaL287gsV2msA%3D%3D (Pubitemid 16175875)
14. S Saadeh ZM Younossi EM Remer, et al. 2002 The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 745 750 12198701 10.1053/gast.2002.35354 (Pubitemid 34977081)
15. N Villanova S Moscatiello S Ramilli, et al. 2005 Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease Hepatology 42 473 480 15981216 10.1002/hep.20781 (Pubitemid 41061101)
16. P Salvi R Ruffini D Agnoletti, et al. 2010 Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study J Hypertens 28 1699 1707 20467324 10.1097/HJH.0b013e32833a7de6 1:CAS:528:DC%2BC3cXptVCmsr0%3D
17. C Vlachopoulos E Manesis K Baou, et al. 2010 Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: a pilot study Am J Hypertens 23 1183 1189 20634799 10.1038/ajh.2010.144
18. SH Park BI Kim JW Yun, et al. 2004 Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men J Gastroenterol Hepatol 19 694 698 15151626 10.1111/j.1440-1746.2004.03362.x 1:CAS:528:DC%2BD2cXlvFOlsbo%3D (Pubitemid 38858204)
19. CC Wang SK Lin YF Tseng, et al. 2009 Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease J Gastroenterol Hepatol 24 1411 1416 19702910 10.1111/j.1440-1746.2009.05872.x
20. T Kogiso Y Moriyoshi S Shimizu H Nagahara K Shiratori 2009 High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike information criterion scoring system in the general Japanese population J Gastroenterol 44 313 321 19271113 10.1007/s00535-009-0002-5 1:CAS:528:DC%2BD1MXkt1yitb8%3D
21. A Wieckowska BG Papouchado Z Li, et al. 2008 Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis Am J Gastroenterol 103 1372 1379 18510618 10.1111/j.1572-0241.2007.01774.x 1:CAS:528:DC%2BD1cXos1Wrt7g%3D (Pubitemid 351813900)
22. IH Bahcecioglu M Yalniz H Ataseven, et al. 2005 Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients in nonalcoholic steatohepatitis Heaptogastroenterology 52 1549 1553 1:CAS:528:DC%2BD2MXhtFChtrrO (Pubitemid 41391035)
23. YJ Lee HR Lee JY Shim BS Moon JH Lee JK Kim 2010 Relationship between white blood cell count and nonalcoholic fatty liver disease Dig Liver Dis 42 888 894 20472517 10.1016/j.dld.2010.04.005
24. K Bhagat P Vallance 1999 Effect of cytokines on nitric oxide pathways in human vasculature Curr Opin Nephrol Hypertens 8 89 96 9914865 10.1097/00041552-199901000-00014 1:STN:280:DyaK1M7htlaqtg%3D%3D (Pubitemid 29083405)
25. MB Kahaleh PS Fan 1997 Effect of cytokines on the production of endothelin by endothelial cells Clin Exp Rheumatol 15 163 167 9196868 1:STN:280:DyaK2szktVeluw%3D%3D (Pubitemid 27224652)
26. R Bataller P Sancho-Bru P Ginès, et al. 2003 Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II Gastroenterology 125 117 125 12851877 10.1016/S0016-5085(03) 00695-4 1:CAS:528:DC%2BD3sXmtVWqur4%3D (Pubitemid 36799113)
27. S Sookoian GO Castaño AL Burgueño, et al. 2009 Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease Atherosclerosis 209 585 591 19896127 10.1016/j.atherosclerosis.2009.10.011
28. G Targher L Bertolini S Rodella, et al. 2007 Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients Diabetes Care 30 2119 2121 17519430 10.2337/dc07-0349 1:CAS:528:DC%2BD2sXpsleks7Y%3D (Pubitemid 47219432)
29. W Dunn R Xu DL Wingard, et al. 2008 Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study Am J Gastroenterol 103 2263 2271 18684196 10.1111/j.1572-0241.2008.02034.x
30. LA Adams JF Lymp J St Sauver, et al. 2005 The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 113 121 16012941 10.1053/j.gastro.2005.04.014 (Pubitemid 41002048)
31. G Bedogni L Miglioli F Masutti C Tiribelli G Marchesini S Bellentani 2005 Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study Hepatology 42 44 52 15895401 10.1002/hep.20734 (Pubitemid 40911310)
32. S Zelber-Sagi D Nitzan-Kaluski Z Halpern R Oren 2006 Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures Liver Int 26 856 863 16911469 10.1111/j.1478-3231.2006.01311.x (Pubitemid 44165254)
33. S Jimba T Nakagami M Takahashi, et al. 2005 Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults Diabet Med 22 1141 1145 16108839 10.1111/j.1464-5491.2005.01582. x 1:CAS:528:DC%2BD2MXhtVOlt7%2FO (Pubitemid 41224170)
34. SH Saverymuttu AE Joseph JD Maxwell 1986 Ultrasound scanning in the detection of hepatic fibrosis and steatosis Br Med J 292 13 15 10.1136/bmj.292.6512.13 1:STN:280:DyaL287gsV2msA%3D%3D (Pubitemid 16175875)